13d
Hosted on MSNAI-designed proteins revolutionize snakebite treatmentResearch highlights the potential of deep learning in creating proteins that neutralize snake venom, offering new solutions ...
It has been a few years since AI began successfully tackling the challenge of predicting the three-dimensional structure of proteins, complex molecules that are essential for all life. Next-generation ...
located at the extracellular end of the nicotinic acetylcholine receptor (AChR) α subunit, and investigated its clinical relevance in myasthenia gravis (MG). Methods In this retrospective cohort study ...
is a common neuromuscular junction disorder that is primarily mediated by anti-acetylcholine receptor antibodies (AChR-Ab). However, using AChR-Ab titers to predict MG severity and improvement remains ...
Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction; it is primarily caused by the production of anti-acetylcholine receptor ... IgG1 antibody Fc fragment that binds ...
Potential drugs targeting the pathways involved in synaptic plasticity, such as GABA signaling and NMDA receptor function ... which typically breaks acetylcholine. This drug’s main pharmacological ...
You’ll receive it weekly for 4 weeks, followed by every 2 weeks, and is approved for people who have tested positive for anti-acetylcholine receptor antibodies. Taking eculizumab may increase ...
The mRNA CAR-T modality collects T-cells from a patient using a personalized approach, and adds a CAR, or a chimeric antigen receptor, to the cell using mRNA. The company says in its 10-K that ...
In other words, "the cannabinoid receptors were seen to be activated and the acetylcholine levels in the brain to be increased. The drug restored the cholinergic system and improved memory", added ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results